We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

GlaxoSmithKline and Santaris Pharma Enter Global R&D Alliance

News   Dec 24, 2007

 
GlaxoSmithKline and Santaris Pharma Enter Global R&D Alliance
 
 
 

RELATED ARTICLES

Timing Is Key in Cell Protein Production

News

Scientists at the University of Sheffield have discovered how genes create proteins in research which could aid the development of treatments for human diseases.

READ MORE

Stem Cell Resilience Model of Oculomotor Neurons a Boost for ALS Research

News

A stem cell-based model of neuron resilience has been developed to help identify genes contributing to resilience, with the possibility of leveraging the findings in gene therapy to strengthen sensitive motor neurons.

READ MORE

Designing “Smart” Drugs to Prevent Malaria Treatment Resistance

News

Researchers at the Crick and Imperial College London have generated malaria parasites resistant to a promising new class of candidate antimalarial drugs. By analyzing the structural changes behind the resistance, they identified novel compounds that were immune to this mechanism of resistance.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE